BIOMAT Database Logo BIOMAT Database Logo

Phase II study of spirogermanium in advanced breast cancer. 1984

J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005857 Germanium A rare metal element with a blue-gray appearance and atomic symbol Ge, atomic number 32, and atomic weight 72.63.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II trial of spirogermanium for treatment of advanced breast cancer.
February 1983, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II study of spirogermanium in advanced ovarian malignancy.
January 1981, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II study of spirogermanium in the treatment of metastatic breast cancer.
September 1984, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
A phase II study of spirogermanium in advanced human malignancy.
August 1985, American journal of clinical oncology,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
May 1986, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II study of spirogermanium in metastatic prostate cancer.
September 1986, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II study of spirogermanium in patients with advanced colorectal carcinoma.
January 1986, Investigational new drugs,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
February 1983, Cancer treatment reports,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
A phase II study of spirogermanium in patients with advanced malignant lymphoma.
July 1989, Investigational new drugs,
J P Kuebler, and D C Tormey, and G R Harper, and Y C Chang, and J D Khandekar, and G Falkson
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
July 1989, Investigational new drugs,
Copied contents to your clipboard!